News
DGX
206.86
-1.18%
-2.46
Quest Diagnostics MRD Blood Test May Support Growth In Higher Value Oncology
Simply Wall St · 19h ago
Quest Diagnostics Is Maintained at Outperform by Mizuho
Dow Jones · 23h ago
Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $235
Benzinga · 23h ago
Quest Diagnostics price target raised to $235 from $210 at Mizuho
TipRanks · 1d ago
Analysts Are Bullish on These Healthcare Stocks: Doximity (DOCS), Quest Diagnostics (DGX)
TipRanks · 1d ago
Forecasting The Future: 6 Analyst Projections For Quest Diagnostics
Benzinga · 1d ago
Quest Diagnostics Price Target Raised to $220.00/Share From $205.00 by Truist Securities
Dow Jones · 1d ago
Quest Diagnostics Is Maintained at Hold by Truist Securities
Dow Jones · 1d ago
Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $220
Benzinga · 1d ago
Quest Diagnostics Is Maintained at Neutral by UBS
Dow Jones · 1d ago
UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $210
Benzinga · 1d ago
Quest Diagnostics Is Maintained at In-Line by Evercore ISI Group
Dow Jones · 1d ago
Quest Diagnostics Price Target Raised to $220.00/Share From $190.00 by Evercore ISI Group
Dow Jones · 1d ago
Quest Diagnostics Price Target Raised to $225.00/Share From $210.00 by Barclays
Dow Jones · 1d ago
Quest Diagnostics Is Maintained at Overweight by Barclays
Dow Jones · 1d ago
Evercore ISI Group Maintains In-Line on Quest Diagnostics, Raises Price Target to $220
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Quest Diagnostics (DGX) and OrganiGram Holdings (OGI)
TipRanks · 1d ago
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $225
Benzinga · 1d ago
Quest Diagnostics price target raised to $210 from $190 at UBS
TipRanks · 1d ago
Quest Diagnostics price target raised to $220 from $205 at Truist
TipRanks · 1d ago
More
Webull provides a variety of real-time DGX stock news. You can receive the latest news about Quest Diagnostics Inc through multiple platforms. This information may help you make smarter investment decisions.
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.